A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 2.66 EUR -0.75%
Market Cap: 202.2m EUR

Net Margin
Atrys Health SA

-11.1%
Current
-17%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-11.1%
=
Net Income
-24.6m
/
Revenue
221.1m

Net Margin Across Competitors

No Stocks Found

Atrys Health SA
Glance View

Market Cap
201.8m EUR
Industry
Health Care

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

ATRY Intrinsic Value
3.64 EUR
Undervaluation 27%
Intrinsic Value
Price
A
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-11.1%
=
Net Income
-24.6m
/
Revenue
221.1m
What is the Net Margin of Atrys Health SA?

Based on Atrys Health SA's most recent financial statements, the company has Net Margin of -11.1%.

Back to Top